Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Cell/Gene Tx channel feed
Updated: Cell therapy biotech Affini-T Therapeutics reduces staff
3 months ago
People
Cell therapy startup Aurion files for IPO, despite ongoing legal battle with investor Alcon
3 months ago
Financing
Law
UK biotech launches with T cell therapy technology to treat solid tumors
3 months ago
Startups
Manufacturing
Chinese startup begins first trial of in vivo CRISPR therapy for blood disease
3 months ago
R&D
China
FDA rejects Atara's cell therapy for rare transplant complication, stock craters
3 months ago
FDA+
Vertex's bid to offer Casgevy fertility support is 'self-serving,' HHS says
3 months ago
Pharma
Law
Umoja’s $100M Series C will advance its bid for more convenient cell therapies
4 months ago
Financing
Post-Hoc: The embryo editing debate is back
4 months ago
China
Exclusive: Bucking gene editing downturn, Tune raises $175M to bring epigenetic editing to clinic
4 months ago
Financing
Shoreline cuts staff as its partnership with Gilead's Kite is now in flux
4 months ago
People
Exclusive: First-of-its-kind infant DNA edit leads to apparent cure in disease that set back field 25 years ago
4 months ago
R&D
Astellas stops developing autologous cell therapy using tech from Xyphos buyout
4 months ago
R&D
Pharma
Vertex signs in vivo gene editing delivery pact for sickle cell and thalassemia as it looks beyond Casgevy
4 months ago
Deals
R&D
Pfizer ends work on Sangamo's hemophilia gene therapy, crushing biotech's hopes
4 months ago
R&D
WuXi AppTec will sell cell and gene therapy business to private equity firm
4 months ago
China
Manufacturing
Mesoblast wins long-awaited approval for cell therapy
4 months ago
Pharma
FDA+
Sangamo strikes another brain-targeting AAV partnership, this time with Astellas
4 months ago
Deals
Updated: Flagship gene therapy startup Ring Therapeutics nearly halves workforce as CEO departs
4 months ago
People
Startups
Exclusive: Cell therapy startup Shinobi adds Borges as science chief, Katz as top medical officer
4 months ago
People
Startups
Bristol Myers drops cell therapy pacts with Immatics, Century as part of portfolio review
4 months ago
Deals
R&D
Roche terminates a Phase 3 Spark gene therapy in hemophilia A
4 months ago
R&D
Editas to cut 65% of workforce, officially stops work on ex vivo sickle cell therapy
5 months ago
R&D
Chroma, Nvelop merge to form nChroma Bio, raising $75M to enter the clinic
5 months ago
Financing
Deals
Arcellx and Gilead seek to unseat Legend and J&J with multiple myeloma cell therapy
5 months ago
R&D
Pharma
First page
Previous page
1
2
3
4
5
6
Next page
Last page